Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1206.92	-26793.39	2050.12
Graham Fair Price	-31.27	8.68	12.63
PEG	-154.97	-9.42	-3.69
Price/Book	0.61	22.28	22.14
Price/Cash Flow	-13.06	324.20	372.92
Prices/Earnings	153.20	1360.01	-537.13
Price/Sales	4.09	52.28	50.23
Price/FCF	-13.06	324.20	372.92
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.20	0.85	0.85
Operating Margin	13.09	-0.04	-0.04
ROA	-58.04	< 0.005	< 0.005
ROE	-0.01	< 0.005	-60.26
ROIC	-0.02	< 0.005	47.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	1868.45
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.19	0.08	-59.22
EPS QOQ	-1.45	1.44	-0.69
FCF QOQ	0.30	0.27	-8.41
Revenue QOQ	0.04	0.06	39.64
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	100.86	< 0.005	-100.00
Days Sales Outstanding (DSO)	45.67	38.90	-14.83
Inventory Turnover	0.89	95088000.00	10655734867.00
Debt/Capitalization	0.37	0.25	-32.43
Quick Ratio	1.76	1.86	5.68
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26.22	28.59	9.03
Cash	27.57	29.96	8.66
Capex	-0.52	-0.54	-5.38
Free Cash Flow	1.56	1.96	26.19
Revenue	11.56	12.18	5.38
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.96	1.96	-0.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.67	-268.09	869.04
Naive Interpretation	Member

06 - Financial Health · Weak

Rating